Efficacy of propolis as an adjunct treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trial

Marcelo Augusto Duarte Silveira(D’Or Institute for Research and Education), Erica Batista dos Santos Galvão(D’Or Institute for Research and Education), Suzete Nascimento Farias da Guarda(Universidade Federal da Bahia), Raíssa Lanna Araújo San Martin(D’Or Institute for Research and Education), Márcio de Oliveira Silva(D’Or Institute for Research and Education), Rogério da Hora Passos(Yahoo (Spain)), Silviana Salles Ultchak(D’Or Institute for Research and Education), Marcel Miranda Dantas Gomes(D’Or Institute for Research and Education), Andresa Aparecida Berretta(Universidade de São Paulo), Lucas Diniz da Conceição(D’Or Institute for Research and Education), Maurício Brito Teixeira(Universidade do Estado da Bahia), Thais Chaves Amorim(D’Or Institute for Research and Education), Fabio Santos Amorim(D’Or Institute for Research and Education), Lis Moreno(D’Or Institute for Research and Education), David De Jong(Universidade de Ribeirão Preto), João Gabriel Rosa(D’Or Institute for Research and Education), Julio Cezar Miranda Sampaio(D’Or Institute for Research and Education), Sérgio Pinto de Souza(Escola Bahiana de Medicina e Saúde Pública), Monique Lírio(D’Or Institute for Research and Education), Paulo Benígno Pena Batista(D’Or Institute for Research and Education), Marcele Helena Celestino Alves dos Santos(D’Or Institute for Research and Education), Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública), Thiago Cerqueira‐Silva(Universidade Federal da Bahia), Renata Mendonça(D’Or Institute for Research and Education)
medRxiv
January 9, 2021
10.1101/2021.01.08.20248932
Cited by 14

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
|The Lancet|2022|467
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil
|Emerging infectious diseases|2021|215
Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial
|Biomedicine & Pharmacotherapy|2021|121